COIOSDeep risk insights through multi-disciplinary research across the globe
brown wooden wall with brown wooden door
Item new Peer-reviewed Added

No study has yet followed snus or e-cigarette users through chemotherapy

A review to June 2026 found no study of how snus or e-cigarettes affect response to chemotherapy, and the one laboratory signal of drug resistance did not replicate.

The review searched three databases to June 2026 and found no study of how snus or e-cigarettes affect response to chemotherapy. Snus use has been linked to a higher risk of dying from cancer, with weaker evidence of the same kind for e-cigarettes. One laboratory study linked e-cigarette exposure to changes in drug transporter expression and cisplatin resistance, but a multi-centre repeat did not confirm it.

Why it is interesting: Names a gap: what these products do during cancer treatment has not been measured in patients.

Source
Toxicology Mechanisms and Methods, 14 September 2026
Paper
Alternative tobacco and nicotine products during anticancer therapy: a systematic review of mechanistic toxicology evidence, treatment-resistance signals, and potential hazards
Authors
Kopa-Stojak PN, Pawliczak R
DOI
10.1080/15376516.2026.2726966
Type
Peer-reviewed article
Design
Systematic review of mechanistic, in vitro and observational studies searched in PubMed, Embase and Web of Science to June 2026; no epidemiological studies identified
Verdict
New finding
Driver
Cancer

Other drivers in Health today